GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nutraceutical International Corp (NAS:NUTR) » Definitions » Peter Lynch Fair Value

Nutraceutical International (Nutraceutical International) Peter Lynch Fair Value : $8.63 (As of Apr. 26, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Nutraceutical International Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Here, as of today, Nutraceutical International's PEG is 1. Nutraceutical International's 5-Year TTM EBITDA Growth Rate is 5.57. Nutraceutical International's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2017 was $1.55. Therefore, the Peter Lynch Fair Value for today is $8.63.

As of today (2024-04-26), Nutraceutical International's share price is $41.80. Nutraceutical International's Peter Lynch fair value is $8.63. Therefore, Nutraceutical International's Price to Peter Lynch Fair Value Ratio for today is 4.84.


The historical rank and industry rank for Nutraceutical International's Peter Lynch Fair Value or its related term are showing as below:



NUTR's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 1.045
* Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Nutraceutical International Peter Lynch Fair Value Historical Data

The historical data trend for Nutraceutical International's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nutraceutical International Peter Lynch Fair Value Chart

Nutraceutical International Annual Data
Trend Sep07 Sep08 Sep09 Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16
Peter Lynch Fair Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 8.05 12.20

Nutraceutical International Quarterly Data
Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.98 12.20 12.66 12.44 8.63

Competitive Comparison of Nutraceutical International's Peter Lynch Fair Value

For the Packaged Foods subindustry, Nutraceutical International's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nutraceutical International's Price-to-Peter-Lynch-Fair-Value Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Nutraceutical International's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Nutraceutical International's Price-to-Peter-Lynch-Fair-Value falls into.



Nutraceutical International Peter Lynch Fair Value Calculation

Nutraceutical International's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* 5.57 *1.55
=8.63

Nutraceutical International's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.55.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Nutraceutical International  (NAS:NUTR) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 5.57 instead of 15 in this case.

Nutraceutical International's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=41.80/8.63
=4.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nutraceutical International Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Nutraceutical International's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Nutraceutical International (Nutraceutical International) Business Description

Traded in Other Exchanges
N/A
Address
Nutraceutical International Corp was incorporated in Delaware in 1993. The Company is a manufacturer, marketer, distributor and retailer of branded nutritional supplements and other natural products sold to and through domestic health and natural food stores. Internationally, it markets and distributes branded nutritional supplements and other natural products to and through health and natural product distributors and retailers. Its core business is to acquire, integrate and operate businesses in the natural products industry that manufacture, market and distribute branded nutritional supplements. The Company manufactures and sells nutritional supplements and other natural products under numerous brands, including Solaray, KAL, Dynamic Health, Nature's Life, LifeTime, Natural Balance, NaturalCare, Health from the Sun, Pioneer, Nutra BioGenesis, Life-flo, Organix South, Heritage Store and Monarch Nutraceuticals. It owns neighborhood natural food markets, which operates under the trade names The Real Food Company, Thom's Natural Foods, Cornucopia Community Market and Granola's. It also owns health food stores, which operates under various trade names, including Fresh Vitamins and Peachtree Natural Foods. The Company's products includes vitamins and minerals, herbs, specialty formulas, personal care products, liquid nutritional products, homeopathics, functional foods and other products.
Executives
J Kimo Esplin director C/O NUTRACEUTICAL INTERNATIONAL CORP, 1400 KEARNS BLVD, PARK CITY UT 84060
Bain Capital Investors Llc 10 percent owner 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Fund Iv Lp 10 percent owner C/O BAIN CAPITAL LLC, TWO COPLEY PLACE, BOSTON MA 02199
Bcip Trust Associates Lp 10 percent owner C/O BAIN CAPITAL LLC, 111 HUNINGTON AVENUE, BOSTON MA 02199
Robert C Gay director C/O BAIN CAPITAL INC TWO COPLEY PLACE, BOSTON MA 02116
Matthew S Levin director BAIN CAPITAL PARTNERS LLC JOHN HANCOCK TOWER, 200 CLARENDON STREET BOSTON MA 02116
Associates Bcip 10 percent owner

Nutraceutical International (Nutraceutical International) Headlines